HU9603342D0 - Quinoline derivatives as leukotriene antagonists - Google Patents
Quinoline derivatives as leukotriene antagonistsInfo
- Publication number
- HU9603342D0 HU9603342D0 HU9603342D HU9603342D HU9603342D0 HU 9603342 D0 HU9603342 D0 HU 9603342D0 HU 9603342 D HU9603342 D HU 9603342D HU 9603342 D HU9603342 D HU 9603342D HU 9603342 D0 HU9603342 D0 HU 9603342D0
- Authority
- HU
- Hungary
- Prior art keywords
- quinoline derivatives
- leukotriene antagonists
- leukotriene
- antagonists
- quinoline
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/12—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/18—Halogen atoms or nitro radicals
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Pain & Pain Management (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Immunology (AREA)
- Pulmonology (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Rheumatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB9414590A GB9414590D0 (en) | 1994-07-20 | 1994-07-20 | Chemical compounds |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| HU9603342D0 true HU9603342D0 (en) | 1997-01-28 |
Family
ID=10758585
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HU9603342A HUT76443A (en) | 1994-07-20 | 1995-06-07 | Quinoline derivatives as leukotriene antagonists,pharmaceutical compositions containing them and process for producing them |
| HU9603342D HU9603342D0 (en) | 1994-07-20 | 1995-06-07 | Quinoline derivatives as leukotriene antagonists |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HU9603342A HUT76443A (en) | 1994-07-20 | 1995-06-07 | Quinoline derivatives as leukotriene antagonists,pharmaceutical compositions containing them and process for producing them |
Country Status (13)
| Country | Link |
|---|---|
| EP (1) | EP0773931A1 (en) |
| JP (1) | JPH10504026A (en) |
| KR (1) | KR970704691A (en) |
| CN (1) | CN1152915A (en) |
| AU (1) | AU686820B2 (en) |
| CA (1) | CA2192478A1 (en) |
| CZ (1) | CZ284799B6 (en) |
| FI (1) | FI970143A (en) |
| GB (1) | GB9414590D0 (en) |
| HU (2) | HUT76443A (en) |
| NZ (1) | NZ287850A (en) |
| PL (1) | PL318106A1 (en) |
| WO (1) | WO1996002506A1 (en) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2761687B1 (en) | 1997-04-08 | 2000-09-15 | Centre Nat Rech Scient | QUINOLEIN DERIVATIVES, ESPECIALLY HAVING ANTIVIRAL PROPERTIES, THEIR PREPARATIONS AND THEIR BIOLOGICAL APPLICATIONS |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB8728051D0 (en) * | 1987-12-01 | 1988-01-06 | Leo Pharm Prod Ltd | Chemical compounds |
| US4918081A (en) * | 1988-06-20 | 1990-04-17 | Rorer Pharmaceutical Corp. | Quinoline derivatives and use thereof as antagonists of leukotriene d4 |
| GB9216768D0 (en) * | 1992-08-07 | 1992-09-23 | Leo Pharm Prod Ltd | Chemical compounds |
-
1994
- 1994-07-20 GB GB9414590A patent/GB9414590D0/en active Pending
-
1995
- 1995-06-07 NZ NZ287850A patent/NZ287850A/en unknown
- 1995-06-07 CA CA002192478A patent/CA2192478A1/en not_active Abandoned
- 1995-06-07 WO PCT/DK1995/000223 patent/WO1996002506A1/en not_active Application Discontinuation
- 1995-06-07 HU HU9603342A patent/HUT76443A/en unknown
- 1995-06-07 CN CN95194167A patent/CN1152915A/en active Pending
- 1995-06-07 HU HU9603342D patent/HU9603342D0/en unknown
- 1995-06-07 JP JP8504596A patent/JPH10504026A/en active Pending
- 1995-06-07 KR KR1019970700296A patent/KR970704691A/en not_active Application Discontinuation
- 1995-06-07 CZ CZ963529A patent/CZ284799B6/en not_active IP Right Cessation
- 1995-06-07 AU AU26696/95A patent/AU686820B2/en not_active Ceased
- 1995-06-07 PL PL95318106A patent/PL318106A1/en unknown
- 1995-06-07 EP EP95921729A patent/EP0773931A1/en not_active Withdrawn
-
1997
- 1997-01-14 FI FI970143A patent/FI970143A/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| PL318106A1 (en) | 1997-05-12 |
| CZ352996A3 (en) | 1997-10-15 |
| KR970704691A (en) | 1997-09-06 |
| WO1996002506A1 (en) | 1996-02-01 |
| GB9414590D0 (en) | 1994-09-07 |
| AU686820B2 (en) | 1998-02-12 |
| CN1152915A (en) | 1997-06-25 |
| HUT76443A (en) | 1997-09-29 |
| EP0773931A1 (en) | 1997-05-21 |
| NZ287850A (en) | 1998-05-27 |
| CZ284799B6 (en) | 1999-03-17 |
| CA2192478A1 (en) | 1996-02-01 |
| FI970143A0 (en) | 1997-01-14 |
| FI970143A (en) | 1997-01-14 |
| JPH10504026A (en) | 1998-04-14 |
| AU2669695A (en) | 1996-02-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AP9500745A0 (en) | Quinoline derivatives | |
| CY2505B1 (en) | Quinoline derivatives as nk3 antagonists | |
| IL143782A0 (en) | Quinoline derivatives | |
| PL343420A1 (en) | Quinoline derivatives | |
| PL345388A1 (en) | Quinoline derivatives | |
| IL124522A0 (en) | Quinoline derivatives | |
| HK1035716A1 (en) | Quinoline derivatives | |
| IL128141A0 (en) | Tetrahydroquinoline derivatives as eaa antagonists | |
| HK1034079A1 (en) | Tetrahydroquinoline derivatives as glycine antagonists | |
| GB9404378D0 (en) | Quinoline derivatives | |
| AU2652395A (en) | Leukotriene b4 antagonists | |
| ZA954269B (en) | Quinoline derivatives | |
| GB9402275D0 (en) | Quinoline derivatives | |
| GB9413150D0 (en) | Quinoline derivatives | |
| HU9603342D0 (en) | Quinoline derivatives as leukotriene antagonists | |
| HUP9901134A3 (en) | Quinoline derivatives containing a diol as leukotriene antagonists | |
| GR3033237T3 (en) | Quinoline derivatives as leukoriene antagonists. | |
| IL126806A0 (en) | Quinoline derivatives | |
| GB9413937D0 (en) | Quinoline derivatives | |
| GB9402306D0 (en) | Quinoline derivatives | |
| GB9616476D0 (en) | 6-aryl-(methyl-or methylidone)-quinoline derivatives as voltage-gated | |
| KR950700884A (en) | Quinoline derivatives as leukotriene antagonists | |
| ZA952859B (en) | Substituted pyridine leukotriene by antagonists | |
| SI1086093T1 (en) | Tetrahydroquinoline derivatives as glycine antagonists | |
| GB9711030D0 (en) | Quinoline leukrotriene antagonists |